Skip to Main Content

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) Securities Fraud Class Action

View Complaint
CompanyApellis Pharmaceuticals, Inc.
CourtUnited States District Court for the District of Massachusetts
Case Number24-cv-11470
JudgeHonorable Julia E. Kobick
Class PeriodJanuary 28, 2021 through July 28, 2023
Security TypeCommon Stock

Case Background:

This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Apellis Pharmaceuticals, Inc. ("Apellis") common stock between January 28, 2021 and July 28, 2023, inclusive (the “Class Period”).

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about Apellis’s business and operations.  Specifically, Defendants misrepresented and/or failed to disclose that: (1) the design of SYFOVRE’s clinical trials was insufficient to identify incidents of retinal vasculitis in patients receiving SYFOVRE injections; (2) as a result, the commercial adoption of SYFOVRE was subject to significant, unknown risk factors; and (3) therefore, Defendants’ statements about Apellis’s business, operations, and prospects lacked a reasonable basis at all relevant times.

Current Status of Case:

On March 17, 2025, the Court granted Defendants Motion to Dismiss. Lead Plaintiff filed a Notice of Appeal on April 16, 2025. The appeal is ongoing. 

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP:  Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.  If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Please complete this form relating to your transactions in Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between January 28, 2021 and July 28, 2023.

Click here to print a PDF of this form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Apellis Pharmaceuticals, Inc. prior to the Class Period?
Are you a current or former employee of Apellis Pharmaceuticals, Inc.?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email